 |
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Hydrolase
|
 |
|
Title:
|
 |
Crystal structure of the class d beta-lactamase oxa-13 in complex with meropenem
|
|
Structure:
|
 |
Beta-lactamase. Chain: a, b. Synonym: beta-lactamase oxa-13. Engineered: yes. Other_details: there is an ester link between ser a 67 og and mer a 300 c7 and between ser b 67 og and mer b 300 c7
|
|
Source:
|
 |
Pseudomonas aeruginosa. Organism_taxid: 287. Strain: pae391. Gene: bla oxa-13. Expressed in: escherichia coli. Expression_system_taxid: 562.
|
|
Biol. unit:
|
 |
Homo-Dimer (from PDB file)
|
|
Resolution:
|
 |
|
2.00Å
|
R-factor:
|
0.204
|
R-free:
|
0.257
|
|
|
Authors:
|
 |
L.Pernot,F.Frenois,T.Rybkine,G.L'Hermite,S.Petrella, J.Delettre,V.Jarlier,E.Collatz,W.Sougakoff
|
Key ref:
|
 |
L.Pernot
et al.
(2001).
Crystal structures of the class D beta-lactamase OXA-13 in the native form and in complex with meropenem.
J Mol Biol,
310,
859-874.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
17-Feb-01
|
Release date:
|
12-Jul-01
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
Q51400
(Q51400_PSEAE) -
Beta-lactamase
|
|
|
|
Seq: Struc:
|
 |
 |
 |
266 a.a.
247 a.a.
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
|
|
|
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Biological process
|
peptidoglycan-based cell wall biogenesis
|
2 terms
|
 |
|
Biochemical function
|
penicillin binding
|
2 terms
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
J Mol Biol
310:859-874
(2001)
|
|
PubMed id:
|
|
|
|
|
| |
|
Crystal structures of the class D beta-lactamase OXA-13 in the native form and in complex with meropenem.
|
|
L.Pernot,
F.Frénois,
T.Rybkine,
G.L'Hermite,
S.Petrella,
J.Delettré,
V.Jarlier,
E.Collatz,
W.Sougakoff.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The therapeutic problems posed by class D beta-lactamases, a family of serine
enzymes that hydrolyse beta-lactam antibiotics following an
acylation-deacylation mechanism, are increased by the very low level of
sensitivity of these enzymes to beta-lactamase inhibitors. To gain structural
and mechanistic insights to aid the design of new inhibitors, we have determined
the crystal structure of OXA-13 from Pseudomonas aeruginosa in the apo form and
in complex with the carbapenem meropenem. The native form consisted of a dimer
displaying an overall organisation similar to that found in the closely related
enzyme OXA-10. In the acyl-enzyme complex, the positioning of the antibiotic
appeared to be ensured mainly by (i) the covalent acyl bond and (ii) a strong
salt-bridge involving the carboxylate moiety of the drug. Comparison of the
structures of OXA-13 in the apo form and in complex with meropenem revealed an
unsuspected flexibility in the region of the essential serine 115 residue, with
possible consequences for the catalytic properties of the enzyme. In the apo
form, the Ser115 side-chain is oriented outside the active site, whereas the
general base Lys70 adopts a conformation that seems to be incompatible with the
activation of the catalytic water molecule required for the deacylation step. In
the OXA-13:meropenem complex, a 3.5 A movement of the backbone of the 114-116
loop towards the side-chain of Lys70 was observed, which seems to be driven by a
displacement of the neighbouring 91-104 loop and which results in the
repositioning of the side-chain hydroxyl group of Ser115 toward the catalytic
centre. Concomitantly, the side-chain of Lys70 is forced to curve in the
direction of the deacylating water molecule, which is then strongly bound and
activated by this residue. However, a distance of ca 5 A separates the catalytic
water molecule from the acyl carbonyl group of meropenem, a structural feature
that accounts for the inhibition of OXA-13 by this drug. Finally, the low level
of penicillinase activity revealed by the kinetic analysis of OXA-13 could be
related to the specific presence in position 73 of a serine residue located
close to the general base Lys70, which results in a decrease of the number of
hydrogen-bonding interactions stabilising the catalytic water molecule.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 1.
Figure 1. Superposition of the protein folds of OXA-13 in
the native form (green ribbon) and in complex with meropenem
(red ribbon). Meropenem (stick representation) is in pink. Water
molecules are depicted using red spheres. Hydrogen bonds are
shown as green broken lines.
|
 |
Figure 2.
Figure 2. (a) Superimposition of the active site of OXA-13
(CPK colours) to OXA-10 (in blue, PDB accession code 1FOF). The
protein backbones are shown, with the residues of interest in
stick form. Hydrogen bonds are depicted by green broken lines.
In the OXA-13 model, oxygen atoms are coloured red, carbon atoms
gray and nitrogen atoms blue. The water molecules (HOH) are
indicated by red and blue spheres in OXA-13 and OXA-10,
respectively. The sulfate ion found in the active site of OXA-13
is shown in yellow and red. (b) Detailed view of the
superimposition of OXA-13 (CPK colours) and OXA-10 (PDB entry
code 1FOF ; in blue) in the 70-73 region.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Elsevier:
J Mol Biol
(2001,
310,
859-874)
copyright 2001.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
J.D.Docquier,
M.Benvenuti,
V.Calderone,
F.Giuliani,
D.Kapetis,
F.De Luca,
G.M.Rossolini,
and
S.Mangani
(2010).
Crystal structure of the narrow-spectrum OXA-46 class D beta-lactamase: relationship between active-site lysine carbamylation and inhibition by polycarboxylates.
|
| |
Antimicrob Agents Chemother, 54,
2167-2174.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
S.M.Drawz,
M.Babic,
C.R.Bethel,
M.Taracila,
A.M.Distler,
C.Ori,
E.Caselli,
F.Prati,
and
R.A.Bonomo
(2010).
Inhibition of the class C beta-lactamase from Acinetobacter spp.: insights into effective inhibitor design.
|
| |
Biochemistry, 49,
329-340.
|
 |
|
|
|
|
 |
S.M.Drawz,
and
R.A.Bonomo
(2010).
Three decades of beta-lactamase inhibitors.
|
| |
Clin Microbiol Rev, 23,
160-201.
|
 |
|
|
|
|
 |
K.D.Schneider,
C.R.Bethel,
A.M.Distler,
A.M.Hujer,
R.A.Bonomo,
and
D.A.Leonard
(2009).
Mutation of the active site carboxy-lysine (K70) of OXA-1 beta-lactamase results in a deacylation-deficient enzyme.
|
| |
Biochemistry, 48,
6136-6145.
|
 |
|
|
|
|
 |
K.D.Schneider,
M.E.Karpen,
R.A.Bonomo,
D.A.Leonard,
and
R.A.Powers
(2009).
The 1.4 A crystal structure of the class D beta-lactamase OXA-1 complexed with doripenem.
|
| |
Biochemistry, 48,
11840-11847.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
M.Kalp,
and
P.R.Carey
(2008).
Carbapenems and SHV-1 beta-lactamase form different acyl-enzyme populations in crystals and solution.
|
| |
Biochemistry, 47,
11830-11837.
|
 |
|
|
|
|
 |
E.Santillana,
A.Beceiro,
G.Bou,
and
A.Romero
(2007).
Crystal structure of the carbapenemase OXA-24 reveals insights into the mechanism of carbapenem hydrolysis.
|
| |
Proc Natl Acad Sci U S A, 104,
5354-5359.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
M.Hata,
Y.Fujii,
Y.Tanaka,
H.Ishikawa,
M.Ishii,
S.Neya,
M.Tsuda,
and
T.Hoshino
(2006).
Substrate deacylation mechanisms of serine-beta-lactamases.
|
| |
Biol Pharm Bull, 29,
2151-2159.
|
 |
|
|
|
|
 |
C.V.Gallant,
C.Daniels,
J.M.Leung,
A.S.Ghosh,
K.D.Young,
L.P.Kotra,
and
L.L.Burrows
(2005).
Common beta-lactamases inhibit bacterial biofilm formation.
|
| |
Mol Microbiol, 58,
1012-1024.
|
 |
|
|
|
|
 |
S.Negoro,
T.Ohki,
N.Shibata,
N.Mizuno,
Y.Wakitani,
J.Tsurukame,
K.Matsumoto,
I.Kawamoto,
M.Takeo,
and
Y.Higuchi
(2005).
X-ray crystallographic analysis of 6-aminohexanoate-dimer hydrolase: molecular basis for the birth of a nylon oligomer-degrading enzyme.
|
| |
J Biol Chem, 280,
39644-39652.
|
 |
|
|
|
|
 |
M.S.Wilke,
T.L.Hills,
H.Z.Zhang,
H.F.Chambers,
and
N.C.Strynadka
(2004).
Crystal structures of the Apo and penicillin-acylated forms of the BlaR1 beta-lactam sensor of Staphylococcus aureus.
|
| |
J Biol Chem, 279,
47278-47287.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
N.H.Georgopapadakou
(2004).
Beta-lactamase inhibitors: evolving compounds for evolving resistance targets.
|
| |
Expert Opin Investig Drugs, 13,
1307-1318.
|
 |
|
|
|
|
 |
M.A.Toleman,
K.Rolston,
R.N.Jones,
and
T.R.Walsh
(2003).
Molecular and biochemical characterization of OXA-45, an extended-spectrum class 2d' beta-lactamase in Pseudomonas aeruginosa.
|
| |
Antimicrob Agents Chemother, 47,
2859-2863.
|
 |
|
|
|
|
 |
N.Rhazi,
P.Charlier,
D.Dehareng,
D.Engher,
M.Vermeire,
J.M.Frère,
M.Nguyen-Distèche,
and
E.Fonzé
(2003).
Catalytic mechanism of the Streptomyces K15 DD-transpeptidase/penicillin-binding protein probed by site-directed mutagenesis and structural analysis.
|
| |
Biochemistry, 42,
2895-2906.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
T.Sun,
M.Nukaga,
K.Mayama,
E.H.Braswell,
and
J.R.Knox
(2003).
Comparison of beta-lactamases of classes A and D: 1.5-A crystallographic structure of the class D OXA-1 oxacillinase.
|
| |
Protein Sci, 12,
82-91.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
D.Golemi,
L.Maveyraud,
S.Vakulenko,
J.P.Samama,
and
S.Mobashery
(2001).
Critical involvement of a carbamylated lysine in catalytic function of class D beta-lactamases.
|
| |
Proc Natl Acad Sci U S A, 98,
14280-14285.
|
 |
|
PDB codes:
|
 |
|
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
|